DFTX
Definium Therapeutics
$35.68
+$0.01 (+0.03%)Oct 26, 2026
Key metrics
The numbers that frame DFTX today
- Market cap
- $4.79B
- ROIC
- -198.2%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $10.47
- 52wk High
- $49.70
Growth
Revenue and earnings trend for DFTX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about DFTX
Is Definium Therapeutics a good buy?
Hold. Definium Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Definium Therapeutics is selling at a high price.
What is the market capitalization of DFTX?
Definium Therapeutics's market capitalization is $4.79B.
What is the 52-week high for DFTX stock?
The 52-week high for Definium Therapeutics is $49.70. The current close of $35.68 is 28.2% below that high.
What is the 52-week low for DFTX stock?
The 52-week low for Definium Therapeutics is $10.47. The current close of $35.68 is 240.9% above that low.
Does DFTX stock pay dividends?
Definium Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for DFTX?
Definium Therapeutics's Debt / Equity ratio is 0.04.